figshare
Browse

File(s) not publicly available

Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia

journal contribution
posted on 2024-03-18, 10:36 authored by Kazuya Kashiyama, Yuka Nakazawa, Daniela T Pilz, Chaowan Guo, Mayuko Shimada, Kensaku Sasaki, Heather Fawcett, Jonathan F Wing, Susan O Lewin, Lucinda Carr, Tao-Sheng Li, Alan LehmannAlan Lehmann, et al.
Cockayne syndrome (CS) is a genetic disorder characterized by developmental abnormalities and photodermatosis resulting from the lack of transcription-coupled nucleotide excision repair, which is responsible for the removal of photodamage from actively transcribed genes. To date, all identified causative mutations for CS have been in the two known CS-associated genes, ERCC8 (CSA) and ERCC6 (CSB). For the rare combined xeroderma pigmentosum (XP) and CS phenotype, all identified mutations are in three of the XP-associated genes, ERCC3 (XPB), ERCC2 (XPD), and ERCC5 (XPG). In a previous report, we identified several CS cases who did not have mutations in any of these genes. In this paper, we describe three CS individuals deficient in ERCC1 or ERCC4 (XPF). Remarkably, one of these individuals with XP complementation group F (XP-F) had clinical features of three different DNA-repair disorders - CS, XP, and Fanconi anemia (FA). Our results, together with those from Bogliolo et al., who describe XPF alterations resulting in FA alone, indicate a multifunctional role for XPF. © 2013 The American Society of Human Genetics.

History

Publication status

  • Published

Journal

American Journal of Human Genetics

ISSN

0002-9297

Publisher

Elsevier BV

Issue

5

Volume

92

Page range

807-819

Department affiliated with

  • Sussex Centre for Genome Damage Stability Publications

Institution

University of Sussex

Peer reviewed?

  • Yes